NCT05138770View on ClinicalTrials.gov

Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

August 26, 2022

Study Completion Date

August 30, 2022

Conditions
Inflammatory Bowel Diseases
Interventions
DRUG

VC005 Tablets

VC005 Tablets 1、5、10、25、50、100mg single dose

DRUG

VC005 Tablets Placebo

VC005 Tablets Placebo 1、5、10、25、50、100mg single dose

DRUG

VC005 Tablets food effects group

VC005 Tablets qd per period, for two periods

Trial Locations (1)

Unknown

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

Jiangsu vcare pharmaceutical technology co., LTD

INDUSTRY

NCT05138770 - Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter